Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up registry after sustained virologic response in Gilead-sponsored hepatitis C studies
NL-OMON41568Phase 2Active, not recruiting
- Sponsor
- Gilead Sciences
- Start
- Nov 2013
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in hepatitis C virus infection, sponsored by Gilead Sciences. Primary endpoint: Maintenance of sustained virologic response at Week 144. Started Nov 2013; status: active, not recruiting.
02
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NL-OMON41568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41568.